Media Centre

Featured Media Release

11 Nov 2013 - Monash-GSK pharmaceutical partnership wins two prestigious National B-HERT Collaboration Awards

GSK Australia’s manufacturing R & D team and the Monash Institute of Pharmaceutical Sciences (MIPS) received two industry awards for the Monash-GSK Australian Centre for Innovation and Industrialisation project, a unique research and development partnership that is delivering advanced medicines to the world.


Media Releases

GSK Australia Avandia Update

GlaxoSmithKline (GSK) continues to believe that Avandia is an important treatment option for patients with type 2 diabetes, and is not aware of any legal proceedings having been initiated in Australia in respect of Avandia.



Avandia (rosiglitazone maleate) - Australian Update

Following a review of Avandia® (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration], each agency has today informed GlaxoSmithKline (GSK) of their individual regulatory decisions and resulting...



Avandia (rosiglitazone maleate): GSK Australia spokesperson available post FDA Advisory Group Recommendation.

GlaxoSmithKline (GSK) Australia Medical Director, Dr Camilla Chong will be available to speak with Australian journalists about the outcome of the U.S. Food and Drug Administration (FDA) Advisory Committee recommendation in relation to the...



ViiV Healthcare Lauched in Australia

New specialist HIV company dedicated to delivering advances in HIV treatment and care



GlaxoSmithKline Completes Acquisition of Stiefel

GlaxoSmithKline plc (GSK) announced that it has completed its acquisition of Stiefel


< 3 4 5 6 7 8 9 10 11 12 13